Report Reveals U.S. Export Rules Bar Shipping Vaccines To Five Nations
This article was originally published in PharmAsia News
U.S. export regulations have been revealed to bar vaccines from being sent from the United States to five countries on grounds they export terrorism. Indonesia's health minister said the revelation supports his country's past reluctance to share its avian flu strains with U.S. researchers out of a fear they would not be accessible in developing countries. Under the regulation, vaccines of any type could be denied North Korea, Iran, Cuba, Syria and Sudan on grounds the countries could use them in bioweapons. U.S. health experts questioned about the regulation said they were not aware of the restriction, but said it made no sense because the rule would make it harder to contain an outbreak. (Click here for more
You may also be interested in...
A flurry of financial appointments has been seen across the off-patent industry, involving major players Dr Reddy’s, Biocon, Mayne Pharma and Xbrane Biopharma.
Aurobindo has agreed to sell its US-based Natrol dietary supplements business at a significant premium to the $132.5m it paid in late 2014, as the Indian firm continues to drive into complex formulations in the US, including injectables and biosimilars.
GlaxoSmithKline’s third quarter results included a 9% decline in sales in its vaccine business, but this was offset by tight cost controls and restructuring benefits; the company expects to continue investing in its pipeline and new product launches.